Indefinite Delivery Contract SPE2DX15D9305

This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The IDC has a ceiling value of $499,999,999 and runs through December 31, 2025, allowing the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide.

Under this IDC, DMS Pharmaceutical Group provides a diverse array of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. The delivery orders issued to date cover a wide spectrum of medications such as oncology treatments, contraceptives, auto-injectors, and specialized pharmaceuticals. These firm fixed-price awards do not have any set-aside designations, enabling DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal contracts across multiple product categories and medical domains in support of the Department of Defense's healthcare operations.